Contrast Media

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopa...

Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential for precise quantum sensors in a material that is biocompatible.

August 28, 2012 — GE Healthcare announced important changes to the U.S. product label for Optison (perflutren protein-type A microspheres injectable suspension, USP), a c...

July 31, 2012 — Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food and Drug Administration (FDA) has approved the use of MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic reso...

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort,...
Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.
mri systems contrast media diamonds nanodiamonds cambridge
Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential...
GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture Optison (Perflutren Protein-Type A...
Positron Corp PosiRx 3000-Series Pharmacy Automation Systems
The PosiRx 3000-Series is Positron Corp.'s latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to
Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast...
In July 2012 the U.S. Food and Drug Administration (FDA) granted Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group,...

Articles

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort,...
mri systems contrast media diamonds nanodiamonds cambridge
Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential...
No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue...
Contrast Agents Mayo Clinic Clinical Study Kidney Injury
Many physicians have long believed that the use of intravenous contrast agents for computed tomography (CT) scans can cause acute kidney injury. New Mayo...

Video Center

By Dave Fornell The biggest news item from the American College of Cardiology (ACC) 63rd Annual...
1 week 1 day ago
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be...
3 weeks 1 day ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
4 weeks 22 hours ago
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
CVIS, cardiovascular information system
This webinar reviews multi-ology, multi-site, vendor neutral solutions that transform rigid departmental information silos into fluid, consolidated, information sharing systems. It discusses how to...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live demonstration on Centricity Cardio Enterprise...

Comparison Charts